Qing-Le Zeng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Qing-Le Zeng has a total of 33 co-authors. Here are the top co-authors by number of shared publications:
- Yan-Hao Li
Department of Interventional Radiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
11 shared publications Xiao-Feng He
9 shared publications- Jianbo Zhao
Division of Vascular and Interventional Radiology, Department of General Surgery, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China
7 shared publications Yong Chen
6 shared publicationsYong Chen
5 shared publicationsQue-Lin Mei
4 shared publications
Latest Publications
- Open Access
- 29 October 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1) , 138
Clinical outcomes of total endovascular aortic arch repair by in situ microneedle fenestration using the triple (stiff)-sheathed gutter technique
Purpose: To investigate the outcomes of total endovascular aortic arch repair (TEAAR) via in situ micro-needle fenestration (ISMNF) with the triple (stiff)-sheathed gutter technique. Materials and methods: In this retrospective study, the data of consecutive patients who underwent TEAAR via ISMNF with triple (stiff)-sheathed gutter technique between August 2022 and April 2025 were analyzed. Three 6-Fr, 90-cm sheaths were placed into ascending aorta without removing the dilator and super-stiff guidewires during main stent-graft deployment. This configuration creates a gutter between the stent-graft and aortic wall to maintain perfusion to supra-aortic branches. Operative details, technical success, 30-day and midterm outcomes, and adverse events were recorded. Kaplan–Meier analysis was used to estimate freedom from all-cause death and reintervention. Results: Overall, 36 patients were included. The technical success rate was 94.4% (34/36). Endovascular reconstruction of cervical branches was successfully performed in all cases. The 30-day mortality was 2.8%. The median follow-up period was 19 months (range, 1–32 months). The all-cause death rate was 11.1% (4/36), with no cases of any aorta-related death. The prevalence of endoleaks during follow-up was 13.9% (5/36). The overall stroke rate was 8.3% (3/36). The 1- and 2-year survival rates were 97.3% ± 2.7% and 85.8% ± 8.1%, respectively. The cumulative rate of freedom from reintervention at 1 and 2 years was 87.5% ± 5.9% and 83.2% ± 7.0%, respectively. Conclusion: TEAAR via ISMNF with the triple (stiff)-sheathed gutter technique was performed with a 94% technical success rate and stroke risk similar to open surgery.
- 29 October 2026
- Published by Springer Nature in CVIR Endovascular
- Vol. 9 (1) , 138
Open AccessClinical outcomes of total endovascular aortic arch repair by in situ microneedle fenestration using the triple (stiff)-sheathed gutter technique
Purpose: To investigate the outcomes of total endovascular aortic arch repair (TEAAR) via in situ micro-needle fenestration (ISMNF) with the triple (stiff)-sheathed gutter technique. Materials and methods: In this retrospective study, the data of consecutive patients who underwent TEAAR via ISMNF with triple (stiff)-sheathed gutter technique between August 2022 and April 2025 were analyzed. Three 6-Fr, 90-cm sheaths were placed into ascending aorta without removing the dilator and super-stiff guidewires during main stent-graft deployment. This configuration creates a gutter between the stent-graft and aortic wall to maintain perfusion to supra-aortic branches. Operative details, technical success, 30-day and midterm outcomes, and adverse events were recorded. Kaplan–Meier analysis was used to estimate freedom from all-cause death and reintervention. Results: Overall, 36 patients were included. The technical success rate was 94.4% (34/36). Endovascular reconstruction of cervical branches was successfully performed in all cases. The 30-day mortality was 2.8%. The median follow-up period was 19 months (range, 1–32 months). The all-cause death rate was 11.1% (4/36), with no cases of any aorta-related death. The prevalence of endoleaks during follow-up was 13.9% (5/36). The overall stroke rate was 8.3% (3/36). The 1- and 2-year survival rates were 97.3% ± 2.7% and 85.8% ± 8.1%, respectively. The cumulative rate of freedom from reintervention at 1 and 2 years was 87.5% ± 5.9% and 83.2% ± 7.0%, respectively. Conclusion: TEAAR via ISMNF with the triple (stiff)-sheathed gutter technique was performed with a 94% technical success rate and stroke risk similar to open surgery.
- Open Access
- 11 January 2019
- Published by Springer Nature in BMC Nephrology
- Vol. 20 (1) , 15
Embolization of high-output idiopathic renal arteriovenous fistula primarily using an atrial septal defect occluder via venous access: a case report
The case report is to evaluate the efficacy and safety of embolization of a high-output idiopathic renal arteriovenous fistula (IRAVF) with an atrial septal defect occluder (ASDO) via venous access. A 57-year-old male diagnosed with high-output IRAVF received embolization with an ASDO via renal venous access and compact occlusion with 3 vascular plugs and a detachable elastic coil. The IRAVF was successfully occluded. After a follow-up of 2 months, renal arterial computed tomography angiography (CTA) showed the precise location of the ASDO. No complications were observed after 2 years’ follow-up. Based on present results, embolization of a high-output IRAVF with an ASDO via venous access might be an efficient and safe method.
- 11 January 2019
- Published by Springer Nature in BMC Nephrology
- Vol. 20 (1) , 15
Open AccessEmbolization of high-output idiopathic renal arteriovenous fistula primarily using an atrial septal defect occluder via venous access: a case report
The case report is to evaluate the efficacy and safety of embolization of a high-output idiopathic renal arteriovenous fistula (IRAVF) with an atrial septal defect occluder (ASDO) via venous access. A 57-year-old male diagnosed with high-output IRAVF received embolization with an ASDO via renal venous access and compact occlusion with 3 vascular plugs and a detachable elastic coil. The IRAVF was successfully occluded. After a follow-up of 2 months, renal arterial computed tomography angiography (CTA) showed the precise location of the ASDO. No complications were observed after 2 years’ follow-up. Based on present results, embolization of a high-output IRAVF with an ASDO via venous access might be an efficient and safe method.
- 1 February 2016
- Vol. 36 (2) , 294-6
[Transjugular intrahepatic portosystemic shunt with Viatorr stent grafting: report of 3 cases].
We here report 3 cases successfully treated with transjugular intrahepatic portosystemic shunt using Viatorr stent. The 3 patients were had a diagnosis of liver cirrhosis with portal vein hypertension, and presented with black stool and hematemesis. After the treatment, the patients' portal vein pressures were decreased without black stool or hematemesis. Our success demonstrate the feasibility of using Viatorr stent in transjugular intrahepatic portosystemic shunt.
- 1 February 2016
- Vol. 36 (2) , 294-6
[Transjugular intrahepatic portosystemic shunt with Viatorr stent grafting: report of 3 cases].
We here report 3 cases successfully treated with transjugular intrahepatic portosystemic shunt using Viatorr stent. The 3 patients were had a diagnosis of liver cirrhosis with portal vein hypertension, and presented with black stool and hematemesis. After the treatment, the patients' portal vein pressures were decreased without black stool or hematemesis. Our success demonstrate the feasibility of using Viatorr stent in transjugular intrahepatic portosystemic shunt.
- 23 April 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (12) , 3431-3437
Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications
To introduce a modified transjugular intrahepatic portosystemic shunt (TIPS) procedure, percutaneous transhepatic balloon-assisted TIPS (BA-TIPS), and to evaluate its feasibility and efficacy in patients with chronic totally occluded portal vein thrombosis (CTO-PVT) with symptomatic portal hypertension. Eighteen patients (12 men, six women; mean age 49 years [range, 34–68 years]) with CTO-PVT with symptomatic portal hypertension undergoing BA-TIPS between July 2011 and June 2014 were enrolled in this retrospective study. Rates of technical success, efficacy, and complications were evaluated, and pre- and post-procedure portosystemic gradients compared. Clinical follow-up and periodic assessment of TIPS for patency were performed. BA-TIPS was successful in fourteen patients and converted to open portosystemic shunt placement in four. Mean portosystemic pressure gradient fell from 24.1 ± 2.3 mmHg to 12.1 ± 3.5 mmHg after BA-TIPS (P < 0.01). No procedure-related complications were observed. During a median follow up of 16 months (range, 3–41 months), there was one death from hepatocellular carcinoma, one death from severe heart disease, and shunt dysfunction 16 months after BA-TIPS in one patient. Shunt patency was maintained in the remaining patients without symptoms of recurrence. BA-TIPS is feasible, safe, and effective for CTO-PVT with symptomatic portal hypertension. • Transjugular intrahepatic portosystemic shunt is an important treatment for portal vein thrombosis (PVT). • TIPS is challenging for patients with chronic totally occluded portal vein thrombosis (CTO-PVT). • The use of a balloon increased the technical success of portal puncture. • Balloon-assisted TIPS (BA-TIPS) is feasible, safe, and effective for CTO-PVT.
- 23 April 2015
- Published by Springer Nature in European Radiology
- Vol. 25 (12) , 3431-3437
Percutaneous transhepatic balloon-assisted transjugular intrahepatic portosystemic shunt for chronic, totally occluded, portal vein thrombosis with symptomatic portal hypertension: procedure technique, safety, and clinical applications
To introduce a modified transjugular intrahepatic portosystemic shunt (TIPS) procedure, percutaneous transhepatic balloon-assisted TIPS (BA-TIPS), and to evaluate its feasibility and efficacy in patients with chronic totally occluded portal vein thrombosis (CTO-PVT) with symptomatic portal hypertension. Eighteen patients (12 men, six women; mean age 49 years [range, 34–68 years]) with CTO-PVT with symptomatic portal hypertension undergoing BA-TIPS between July 2011 and June 2014 were enrolled in this retrospective study. Rates of technical success, efficacy, and complications were evaluated, and pre- and post-procedure portosystemic gradients compared. Clinical follow-up and periodic assessment of TIPS for patency were performed. BA-TIPS was successful in fourteen patients and converted to open portosystemic shunt placement in four. Mean portosystemic pressure gradient fell from 24.1 ± 2.3 mmHg to 12.1 ± 3.5 mmHg after BA-TIPS (P < 0.01). No procedure-related complications were observed. During a median follow up of 16 months (range, 3–41 months), there was one death from hepatocellular carcinoma, one death from severe heart disease, and shunt dysfunction 16 months after BA-TIPS in one patient. Shunt patency was maintained in the remaining patients without symptoms of recurrence. BA-TIPS is feasible, safe, and effective for CTO-PVT with symptomatic portal hypertension. • Transjugular intrahepatic portosystemic shunt is an important treatment for portal vein thrombosis (PVT). • TIPS is challenging for patients with chronic totally occluded portal vein thrombosis (CTO-PVT). • The use of a balloon increased the technical success of portal puncture. • Balloon-assisted TIPS (BA-TIPS) is feasible, safe, and effective for CTO-PVT.
- 23 August 2014
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 38 (5) , 1303-1307
T-Stenting-and-Small-Protrusion Technique for Bifurcation Stenoses After End-to-Side Anastomosis of Transplant Renal Artery and External Iliac Artery: Report of Two Cases
Bifurcation stenoses after end-to-side anastomosis of transplant renal artery (TRA) and external iliac artery (EIA), including stenoses at the anastomosis and the iliac artery proximal to the TRA, are rare. In the present article, we report two successfully managed cases of bifurcation stenoses after end-to-side anastomosis of the TRA and EIA using the technique of T-stenting and small protrusion (TAP stenting).
- 23 August 2014
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 38 (5) , 1303-1307
T-Stenting-and-Small-Protrusion Technique for Bifurcation Stenoses After End-to-Side Anastomosis of Transplant Renal Artery and External Iliac Artery: Report of Two Cases
Bifurcation stenoses after end-to-side anastomosis of transplant renal artery (TRA) and external iliac artery (EIA), including stenoses at the anastomosis and the iliac artery proximal to the TRA, are rare. In the present article, we report two successfully managed cases of bifurcation stenoses after end-to-side anastomosis of the TRA and EIA using the technique of T-stenting and small protrusion (TAP stenting).
- 1 December 2009
- Vol. 29 (12) , 2504-5, 2509
[Removal of metallic foreign body in the soft tissue under fluoroscopy: 10 years of experiences].
To summarize our 10-year experience with percutaneous fluoroscopically guided removal (PFGR) of metallic foreign body (MFB) in the soft tissue. PFGR was performed in 65 patients for removing a total of 368 MFBs from the soft tissues. The MFBs ranged from 0.2 to 0.3 cm in length embedded in the soft tissue for 7 days to 8 years. For superficial MFBs, the MFBs were removed directly with curved forceps under real time fluoroscopy. For deep MFBs, trocar technique was applied using the instruments for percutaneous diskectomy, with the outer cannula inserted toward the foreign body under real-time fluoroscopy followed by MFB removal by grasping forceps. A total of 346 MFBs were successfully removed without any serious complications (success rate 94.0%), including 154 removed directly and 192 MFBs with trocal technique. The time of the procedures and radiation exposure for MFB removal was 30 s to 20 min and 1-6 min, respectively. PGFR of MFBs in the soft tissue under fluoroscope is safe and effective. Direct removal using curved forceps is suitable for MFBs in superficial soft tissues, while trocal techniques needs to be utilized for deep MFBs.
- 1 December 2009
- Vol. 29 (12) , 2504-5, 2509
[Removal of metallic foreign body in the soft tissue under fluoroscopy: 10 years of experiences].
To summarize our 10-year experience with percutaneous fluoroscopically guided removal (PFGR) of metallic foreign body (MFB) in the soft tissue. PFGR was performed in 65 patients for removing a total of 368 MFBs from the soft tissues. The MFBs ranged from 0.2 to 0.3 cm in length embedded in the soft tissue for 7 days to 8 years. For superficial MFBs, the MFBs were removed directly with curved forceps under real time fluoroscopy. For deep MFBs, trocar technique was applied using the instruments for percutaneous diskectomy, with the outer cannula inserted toward the foreign body under real-time fluoroscopy followed by MFB removal by grasping forceps. A total of 346 MFBs were successfully removed without any serious complications (success rate 94.0%), including 154 removed directly and 192 MFBs with trocal technique. The time of the procedures and radiation exposure for MFB removal was 30 s to 20 min and 1-6 min, respectively. PGFR of MFBs in the soft tissue under fluoroscope is safe and effective. Direct removal using curved forceps is suitable for MFBs in superficial soft tissues, while trocal techniques needs to be utilized for deep MFBs.
- 1 February 2008
- Vol. 28 (2) , 293-5
[Endovascular graft exclusion with digital subtraction angiography for treatment of Stanford type B aortic dissection].
To assess value of endovascular graft exclusion (EVGE) with digital subtraction angiography (DSA) in the treatment of Stanford type B aortic dissection (AD). On the basis of diagnosis with multi-slice spiral CT (MSCT), DSA was performed in 20 Stanford B AD cases for further diagnostic confirmation and EVGE was conducted for treatment. The DSA findings of the cases and the therapeutic effect of EVGE were evaluated. In the 20 cases of Stanford type B AD, altogether 22 stents were implanted during EVGF with a stent release success rate of 100%. Postoperative examination revealed no obvious leakage or false lumen in 15 cases, and death occurred in 1 case 6 days after the operation due to right renal hemorrhage and infection, and the rest 19 patients were cured and discharged. Follow-up of the patients demonstrated improvement in the clinical symptoms, and MSCT showed that all the dissections were sealed successfully. No severe complications were observed 3 months after the treatment in these patients. DSA can identify the fine anatomy of AD and allowed intraoperative monitoring in EVGE, which is an effective and safe means for treatment of Stanford type B AD.
- 1 February 2008
- Vol. 28 (2) , 293-5
[Endovascular graft exclusion with digital subtraction angiography for treatment of Stanford type B aortic dissection].
To assess value of endovascular graft exclusion (EVGE) with digital subtraction angiography (DSA) in the treatment of Stanford type B aortic dissection (AD). On the basis of diagnosis with multi-slice spiral CT (MSCT), DSA was performed in 20 Stanford B AD cases for further diagnostic confirmation and EVGE was conducted for treatment. The DSA findings of the cases and the therapeutic effect of EVGE were evaluated. In the 20 cases of Stanford type B AD, altogether 22 stents were implanted during EVGF with a stent release success rate of 100%. Postoperative examination revealed no obvious leakage or false lumen in 15 cases, and death occurred in 1 case 6 days after the operation due to right renal hemorrhage and infection, and the rest 19 patients were cured and discharged. Follow-up of the patients demonstrated improvement in the clinical symptoms, and MSCT showed that all the dissections were sealed successfully. No severe complications were observed 3 months after the treatment in these patients. DSA can identify the fine anatomy of AD and allowed intraoperative monitoring in EVGE, which is an effective and safe means for treatment of Stanford type B AD.
- 1 March 2007
- Vol. 27 (3) , 384-6
[Percutaneous intradiscal oxygen-ozone injection for lumbar disc herniation: no need of perioperative antibiotic prophylaxis].
To evaluate the feasibility of no antibiotic administration to prevent infection during the perioperative period of percutaneous intradiscal ozone-injection for treatment of lumbar disc herniation. Seventy-two patients with lumbar disc herniation but normal body temperature as well as normal results of three routine tests (blood, urine, stool) and C-reactive protein (CRP) level were randomly divided into two groups. The patients in prophylaxis group were given cephalothin V(2.0 g) intravenous 30 min before the operation, and the control group did not use any antibiotics. All the patients were injected with 6-10 ml ozone (40 microg/ml) for medical use into the discs with 21G needles under fluoroscopic guidance, followed by 10 ml ozone into the paravertebral space. Three days later the general examinations and CRP measurement were repeated. No infection was found in these patients, nor were any significant differences noted in the results of the examinations between the two groups after controlling in patients with above-normal white blood cell count, neutrophil percentage and CRP level. Prophylaxis antibiotics is not necessary during the perioperative period of percutaneous intradiscal ozone injection for lumbar disc herniation.
- 1 March 2007
- Vol. 27 (3) , 384-6
[Percutaneous intradiscal oxygen-ozone injection for lumbar disc herniation: no need of perioperative antibiotic prophylaxis].
To evaluate the feasibility of no antibiotic administration to prevent infection during the perioperative period of percutaneous intradiscal ozone-injection for treatment of lumbar disc herniation. Seventy-two patients with lumbar disc herniation but normal body temperature as well as normal results of three routine tests (blood, urine, stool) and C-reactive protein (CRP) level were randomly divided into two groups. The patients in prophylaxis group were given cephalothin V(2.0 g) intravenous 30 min before the operation, and the control group did not use any antibiotics. All the patients were injected with 6-10 ml ozone (40 microg/ml) for medical use into the discs with 21G needles under fluoroscopic guidance, followed by 10 ml ozone into the paravertebral space. Three days later the general examinations and CRP measurement were repeated. No infection was found in these patients, nor were any significant differences noted in the results of the examinations between the two groups after controlling in patients with above-normal white blood cell count, neutrophil percentage and CRP level. Prophylaxis antibiotics is not necessary during the perioperative period of percutaneous intradiscal ozone injection for lumbar disc herniation.
- 1 June 2004
- Vol. 24 (6) , 697-9
[18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein].
To investigate whether (18)F-fluorodexyglucose (FDG) uptake in the primary hepatocellular carcinoma (HCC) correlates with serum alpha-fetoprotein (AFP). Forty-five patients with histologically confirmed HCC underwent whole-body (18)F-FDG PET examination. Standardized uptake value (SUV) and tumor-to-nontumor ratio of the SUV (SUVratio) were calculated, and the relationship between serum AFP and glucose metabolism in HCC was analyzed. Of the 45 cases, the primary tumor and metastatic lymph nodes were clearly displayed on PET images in 43 cases and the well-differentiated tumors were shown negative in the other 2 cases. A linear correlation of the AFP with SUV (r=0.426, P<0.05) and SUVratio (r=0.532, P<0.001) was noted. Serum AFP correlates significantly with both SUV and SUN ratio, indicating that AFP is involved in glucose metabolism and cell proliferation in HCC.
- 1 June 2004
- Vol. 24 (6) , 697-9
[18F-Fluorodeoxyglucose uptake in hepatocellular carcinoma on positron emission tomography correlates with alpha-fetoprotein].
To investigate whether (18)F-fluorodexyglucose (FDG) uptake in the primary hepatocellular carcinoma (HCC) correlates with serum alpha-fetoprotein (AFP). Forty-five patients with histologically confirmed HCC underwent whole-body (18)F-FDG PET examination. Standardized uptake value (SUV) and tumor-to-nontumor ratio of the SUV (SUVratio) were calculated, and the relationship between serum AFP and glucose metabolism in HCC was analyzed. Of the 45 cases, the primary tumor and metastatic lymph nodes were clearly displayed on PET images in 43 cases and the well-differentiated tumors were shown negative in the other 2 cases. A linear correlation of the AFP with SUV (r=0.426, P<0.05) and SUVratio (r=0.532, P<0.001) was noted. Serum AFP correlates significantly with both SUV and SUN ratio, indicating that AFP is involved in glucose metabolism and cell proliferation in HCC.
- 1 March 2004
- Vol. 12 (3) , 171-2
[Trancatheter arterial chemoembolization in the treatment of hepatoblastoma].
- 1 March 2004
- Vol. 12 (3) , 171-2
[Trancatheter arterial chemoembolization in the treatment of hepatoblastoma].